Regulation of Expression of MHC Class I Genes
MHC I 类基因表达的调节
基本信息
- 批准号:8552617
- 负责人:
- 金额:$ 53.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AffectAreaAutoantigensAutoimmune DiseasesBerylliumBinding SitesBiological AssayCell Surface ReceptorsComplexDataDependenceDiseaseElementsEnhancersEnsureEventFailureGene ExpressionGene TargetingGeneral Transcription FactorsGenesGenetic TranscriptionGoalsHIVHomeostasisHormonesImmuneImmune responseImmunologic SurveillanceIn VitroIndiumInflammationInvestigationL CellsLeadMHC Class I GenesMajor Histocompatibility ComplexMediatingMolecularMutationPathway interactionsPatternPeptidesPlayPromoter RegionsRecruitment ActivityRegulationRegulatory ElementReporterReporter GenesReportingResearchRoleSequence HomologySignal PathwaySignal TransductionSiteTAF1 geneTimeTissuesTranscription InitiationTranscription Initiation SiteTransfectionTransgenic MiceTumor Antigenscarcinogenesiscytokineextracellularin vivonovelpathogenprogramspromoterresponsetranscription factortumor
项目摘要
Transcription of major histocompatibility complex (MHC) class I genes is regulated by both tissue-specific (basal) and hormone/cytokine (activated) mechanisms. Although promoter-proximal regulatory elements have been characterized extensively, the roles of the core promoter and downstream elements in mediating regulation have been largely undefined. Basal and activated transcriptions of an MHC class I gene target distinct core promoter domains, nucleate distinct transcription initiation complexes and initiate at distinct sites within the promoter. Basal and activated transcription pathways recruit distinct transcription factor complexes to the core promoter elements and target distinct transcription initiation sites. Basal transcription is completely dependent upon the general transcription factor TAF1 whereas activated transcription is TAF1 independent. To further characterize regulation of class I gene expression, we have undertaken to characterize core promoter elements in vivo and to identify novel downstream promoter elements. To understand these mechanisms in more detail, we have characterized elements within the core promoter of the MHC class I gene. The minimal class I core promoter has been localized to a segment between -50 bp and +14 bp. Within this segment are sequences similar to canonical TATA and Inr promoter elements and an Sp1 binding site. In past studies, we have reported that no single element is necessary for expression of a reporter in transient transfection assays. However, we have now examined the dependence of transcription on each of the core promoter elements in the context of the native gene in transgenic mice. Remarkably, in parallel with the transfection data, we find that no single element is necessary for in vivo expression: all of the core promoter mutations result in actively expressed MHC class I genes. Rather, the elements regulate either promoter strength or tissue tissue specific patterns of expression and response to cytokines is markedly affected by the different mutations.We have also found that the downstream region of the MHC class I promoter region, between +1 and +32 bp, contains three novel regulatory elements. One of the elements,E+4, functions to increase transcription. The other two elements, DPE-L1 and DPE-L2 have sequence homology with previously characterized DPE elements, but are mechanistically and functionally distinct from other described DPE elements. Under constitutive conditions, the two DPE-L's act in concert to up-regulate promoter activity, preferentially increasing the use of TSS located at the 5' end of the cluster of multiple start sites. These elements promote constitutive, TAF1-dependent transcription. However, under activated TAF1-independent conditions, only one of the element functions independently as an enhancer. Thus, the downstream regulatory elements associated with the class I promoter function to fine-tune and integrate both intracellular and extracellular signaling pathways to ensure the appropriate level of MHC class I transcription to maintain immune homeostasis. These novel downstream elements are functionally and mechanistically distinct from previously described downstream elements in mammalian promoters. Importantly, we have now identified a second promoter element within the core promoter region. This novel promoter element alone is capable of supporting transcription of a reporter gene in the presence or a heterologous enhancer. Furthermore, it is capable of supporting CIITA-activated transcription of a reporter gene. Most significantly, this novel promoter drives the expression of the native MHC class I gene both in stably transfected L cells and in transgenic mice. Thus, this promoter element, like the first, is capable of supporting both constitutive and activated transcription in vitro and in vivo. The roles of the two distinct promoters in regulating MHC class I transcription is an active area of investigation.
主要组织相容性复合物(MHC)I类基因的转录受组织特异性(基础)和激素/细胞因子(激活)机制调节。尽管启动子促进元的调节元素已被广泛表征,但核心启动子和下游元素在中介调节中的作用在很大程度上是不确定的。 MHC I类靶标不同核心启动子结构域的基础和激活的转录,对不同的转录起始复合物有核并在启动子内的不同位点启动。基础和激活的转录途径将不同的转录因子复合物募集到核心启动子元素,并靶向不同的转录起始位点。基础转录完全取决于一般转录因子TAF1,而活化的转录独立于TAF1。为了进一步表征对I类基因表达的调节,我们已承诺表征体内核心启动子元素并确定新型的下游启动子元素。 为了更详细地了解这些机制,我们在MHC I类基因的核心启动子中表征了元素。 最小的I类核心启动子已定位到-50 bp和+14 bp之间。 在该段中,类似于规范tata和INR启动子元素以及SP1结合位点的序列。在过去的研究中,我们报告说,在瞬态转染测定中表达报告基因并不需要单一元素。但是,我们现在检查了转录对转基因小鼠中天然基因的背景下的转录对每个核心启动子元素的依赖性。值得注意的是,与转染数据并行,我们发现体内表达没有任何单个元素是必需的:所有核心启动子突变导致积极表达的MHC I类基因。相反,这些元素调节启动子强度或组织组织特异性表达和对细胞因子反应的特异性模式受到不同突变的显着影响。我们还发现,MHC I类启动子区域的下游区域+1和+32 bp之间包含三个新的调节元素。 其中一个元素E+4的功能增加了转录。其他两个元素DPE-L1和DPE-L2具有先前表征的DPE元素的序列同源性,但在机械上和功能上与其他描述的DPE元素不同。在本构条件下,两个DPE-L的作用协同起到上调启动子活性,优先增加了位于多个起始位点群集的5'端的TSS的使用。 这些元素促进了构成型TAF1依赖性转录。 但是,在激活的TAF1独立条件下,只有一个元素作为增强子独立起作用。因此,与I类启动子功能相关的下游调节元素可以微调和整合细胞内和细胞外信号传导途径,以确保适当的MHC I类转录水平以维持免疫稳态。 这些新型的下游元素在功能和机械上与先前描述的哺乳动物启动子中的下游元素不同。 重要的是,我们现在已经确定了核心启动子区域内的第二个启动子元素。单独的启动子元素能够在存在或异源增强子中支持报告基因的转录。此外,它能够支持记者基因的CIITA激活转录。最重要的是,这种新型启动子在稳定转染的L细胞和转基因小鼠中驱动天然MHC I类基因的表达。因此,该启动子元素像第一个一样,能够在体外和体内支持本构和激活的转录。两个不同启动子在调节MHC I类转录中的作用是一个活跃的研究领域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dinah S. Singer其他文献
Regulation of Major Histocompatibility Complex Class I Gene Expression in Thyroid Cells: ROLE OF THE cAMP RESPONSE ELEMENT-LIKE SEQUENCE
- DOI:
10.1074/jbc.272.32.20096 - 发表时间:
1997-08-08 - 期刊:
- 影响因子:
- 作者:
Motoyasu Saji;Minho Shong;Giorgio Napolitano;Lisa A. Palmer;Shin-Ichi Taniguchi;Masayuki Ohmori;Masanori Ohta;Koichi Suzuki;Susan L. Kirshner;Cesidio Giuliani;Dinah S. Singer;Leonard D. Kohn - 通讯作者:
Leonard D. Kohn
Dinah S. Singer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dinah S. Singer', 18)}}的其他基金
BRD4 Contributes to the Regulation of Alternative Splicing
BRD4 有助于选择性剪接的调控
- 批准号:
10926375 - 财政年份:
- 资助金额:
$ 53.81万 - 项目类别:
The Role of the Cellular Transcription Factor, TAF7, in HIV Biology
细胞转录因子 TAF7 在 HIV 生物学中的作用
- 批准号:
10702824 - 财政年份:
- 资助金额:
$ 53.81万 - 项目类别:
Interactions Between MYC and BRD4 Result in Their Reciprocal Regulation
MYC 和 BRD4 之间的相互作用导致它们的相互调节
- 批准号:
10702727 - 财政年份:
- 资助金额:
$ 53.81万 - 项目类别:
TAF7: A Check-point Regulator in Transcription Initiation
TAF7:转录起始中的检查点调节器
- 批准号:
8175424 - 财政年份:
- 资助金额:
$ 53.81万 - 项目类别:
Responses of MHC Class I Genes to Exogeneous Stimuli
MHC I 类基因对外源刺激的反应
- 批准号:
8157228 - 财政年份:
- 资助金额:
$ 53.81万 - 项目类别:
The Role of the Cellular Transcription Factor, TAF7, in HIV Biology
细胞转录因子 TAF7 在 HIV 生物学中的作用
- 批准号:
10487137 - 财政年份:
- 资助金额:
$ 53.81万 - 项目类别:
Responses of MHC Class I Genes to Exogeneous Stimuli
MHC I 类基因对外源刺激的反应
- 批准号:
7965158 - 财政年份:
- 资助金额:
$ 53.81万 - 项目类别:
TAF7: A Check-point Regulator in Transcription Initiation
TAF7:转录起始中的检查点调节器
- 批准号:
8554051 - 财政年份:
- 资助金额:
$ 53.81万 - 项目类别:
相似国自然基金
跨区域调水工程与区域经济增长:效应测度、机制探究与政策建议
- 批准号:72373114
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
农产品区域公用品牌地方政府干预机制与政策优化研究
- 批准号:72373068
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
新型城镇化与区域协调发展的机制与治理体系研究
- 批准号:72334006
- 批准年份:2023
- 资助金额:167 万元
- 项目类别:重点项目
我国西南地区节点城市在次区域跨国城市网络中的地位、功能和能级提升研究
- 批准号:72364037
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
多时序CT联合多区域数字病理早期预测胃癌新辅助化疗抵抗的研究
- 批准号:82360345
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 53.81万 - 项目类别:
Investigating a novel role of DRAK2 in T cell migration and synapse formation
研究 DRAK2 在 T 细胞迁移和突触形成中的新作用
- 批准号:
10680274 - 财政年份:2023
- 资助金额:
$ 53.81万 - 项目类别:
Defining the autoimmune mechanisms driving human MOG antibody disease pathology
定义驱动人类 MOG 抗体疾病病理学的自身免疫机制
- 批准号:
10748070 - 财政年份:2023
- 资助金额:
$ 53.81万 - 项目类别:
Decoding synovial CD4+ T cell antigen specificities in Rheumatoid Arthritis
解码类风湿性关节炎滑膜 CD4 T 细胞抗原特异性
- 批准号:
10569878 - 财政年份:2023
- 资助金额:
$ 53.81万 - 项目类别:
Elucidating mechanisms of checkpoint inhibitor-induced diabetes
阐明检查点抑制剂诱发糖尿病的机制
- 批准号:
10723194 - 财政年份:2023
- 资助金额:
$ 53.81万 - 项目类别: